Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1341-1346
Published online before print April 21, 2005, doi: 10.1161/01.ATV.0000166601.49954.21
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/7/1341    most recent
01.ATV.0000166601.49954.21v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kazi, M.
Right arrow Articles by Eriksson, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kazi, M.
Right arrow Articles by Eriksson, P.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1341.)
© 2005 American Heart Association, Inc.


Vascular Biology

Difference in Matrix-Degrading Protease Expression and Activity Between Thrombus-Free and Thrombus-Covered Wall of Abdominal Aortic Aneurysm

Monsur Kazi; Chaoyong Zhu; Joy Roy; Gabrielle Paulsson-Berne; Anders Hamsten; Jesper Swedenborg; Ulf Hedin; Per Eriksson

From the Atherosclerosis Research Unit (M.K., C.Z., A.H., P.E.), King Gustav V Research Institute, Department of Medicine, Karolinska Institute; the Department of Vascular Surgery (M.K., J.S., U.H.), Karolinska Hospital, Karolinska Institute; St Görans Hospital (J.R.); and Cardiovascular Research, Center for Molecular Medicine (G.P.-B.), Karolinska Institute, Stockholm, Sweden.

Correspondence to Per Eriksson, King Gustav V Research Institute, Karolinska Institutet, SE-171 76 Stockholm, Sweden. E-mail per.eriksson{at}medks.ki.se

Objective— It has been suggested that the intraluminal thrombus of abdominal aortic aneurysms (AAAs) predisposes for AAA rupture. Here, we examined the possibility that the intraluminal thrombus influences expression and activity of matrix-degrading proteases in the AAA wall.

Methods and Results— Twenty patients undergoing elective repair of AAAs were included. From each patient, specimens from both thrombus-covered and thrombus-free wall were taken for analysis. Gene arrays and quantitative real-time polymerase chain reaction showed that matrix metalloproteinase (MMP)-1, -7, -9, and -12 expressions were upregulated in the thrombus-free wall compared with the thrombus-covered wall. Immunohistochemistry confirmed the differential expression of MMP-9 but also localized MMP-9 to the interface between the thrombus and the underlying vessel wall. MMP-9 expression was colocalized with the presence of macrophages. Similar expression patterns were observed for urokinase plasminogen activator (uPA), uPA receptor, and plasminogen activator inhibitor-1. Gelatinase activity was detected in the same regions as MMP-9 protein expression, ie, within the thrombus-free wall and in the interface between the thrombus and the underlying wall.

Conclusion— The present work demonstrates that protease expression and activity differs within the aneurysm wall. The source and activity of the proteases responsible for the degradation of the thrombus-covered wall need to be further determined.

It has been suggested that the intraluminal thrombus of abdominal aortic aneurysms (AAAs) predisposes for AAA rupture. Differences in gene expression pattern revealed that many MMPs were upregulated in the thrombus-free wall. The source of the proteases responsible for the degradation of the thrombus-covered wall needs to be determined.


Key Words: abdominal aortic aneurysm • thrombus • gene expression • matrix metalloproteinases




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. S. Ikonomidis, J. A. Jones, J. R. Barbour, R. E. Stroud, L. L. Clark, B. S. Kaplan, A. Zeeshan, J. E. Bavaria, J. H. Gorman III, F. G. Spinale, et al.
Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves
J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1028 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. SWEDENBORG and P. ERIKSSON
The Intraluminal Thrombus as a Source of Proteolytic Activity
Ann. N.Y. Acad. Sci., November 1, 2006; 1085(1): 133 - 138.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
X. Houard, A. Leclercq, V. Fontaine, M. Coutard, J.-L. Martin-Ventura, B. Ho-Tin-Noe, Z. Touat, O. Meilhac, and J.-B. Michel
Retention and Activation of Blood-Borne Proteases in the Arterial Wall: Implications for Atherothrombosis
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A3 - A9.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Sarda-Mantel, M. Coutard, F. Rouzet, O. Raguin, J.-M. Vrigneaud, F. Hervatin, G. Martet, Z. Touat, P. Merlet, D. Le Guludec, et al.
99mTc-Annexin-V Functional Imaging of Luminal Thrombus Activity in Abdominal Aortic Aneurysms
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2153 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Z. Touat, V. Ollivier, J. Dai, M.-G. Huisse, A. Bezeaud, U. Sebbag, T. Palombi, P. Rossignol, O. Meilhac, M.-C. Guillin, et al.
Renewal of Mural Thrombus Releases Plasma Markers and Is Involved in Aortic Abdominal Aneurysm Evolution
Am. J. Pathol., March 1, 2006; 168(3): 1022 - 1030.
[Abstract] [Full Text] [PDF]